aspirin has been researched along with Bowel Diseases, Inflammatory in 25 studies
Aspirin: The prototypical analgesic used in the treatment of mild to moderate pain. It has anti-inflammatory and antipyretic properties and acts as an inhibitor of cyclooxygenase which results in the inhibition of the biosynthesis of prostaglandins. Aspirin also inhibits platelet aggregation and is used in the prevention of arterial and venous thrombosis. (From Martindale, The Extra Pharmacopoeia, 30th ed, p5)
acetylsalicylate : A benzoate that is the conjugate base of acetylsalicylic acid, arising from deprotonation of the carboxy group.
acetylsalicylic acid : A member of the class of benzoic acids that is salicylic acid in which the hydrogen that is attached to the phenolic hydroxy group has been replaced by an acetoxy group. A non-steroidal anti-inflammatory drug with cyclooxygenase inhibitor activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether aspirin or non-aspirin non-steroidal anti-inflammatory drugs (NA-NSAIDs) prevent colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD)." | 8.93 | Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease? ( Burr, NE; Hull, MA; Subramanian, V, 2016) |
| " We compared the effects of nimesulide, a preferential COX-2 inhibitor, with those of indomethacin, acetylsalicylic acid (ASA), and dexamethasone in a 24-h model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in the rat." | 7.71 | Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. ( Kankuri, E; Korpela, R; Moilanen, E; Paakkari, I; Vaali, K; Vapaatalo, H, 2001) |
| "Non-aspirin NSAIDs were associated with lower PCCRC risk after a negative baseline colonoscopy." | 5.56 | Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer. ( Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, ICK, 2020) |
| "Twenty-four patients with spondylitis and Crohn's disease or ulcerative colitis, treated with 5-ASA or sulfasalazine, were randomised and assessed by an investigator independent from the spa staff: 12 were submitted to a cycle of mud-bath treatment (12 mud packs and 12 thermal baths over a period of two weeks) and 12 were enrolled as controls." | 5.12 | Mud-bath treatment in spondylitis associated with inflammatory bowel disease--a pilot randomised clinical trial. ( Cardinale, G; Cozzi, F; Dani, L; Oliviero, F; Podswiadek, M; Punzi, L; Sfriso, P, 2007) |
| "To determine whether aspirin or non-aspirin non-steroidal anti-inflammatory drugs (NA-NSAIDs) prevent colorectal cancer (CRC) in patients with inflammatory bowel disease (IBD)." | 4.93 | Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease? ( Burr, NE; Hull, MA; Subramanian, V, 2016) |
| " We compared the effects of nimesulide, a preferential COX-2 inhibitor, with those of indomethacin, acetylsalicylic acid (ASA), and dexamethasone in a 24-h model of 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced colitis in the rat." | 3.71 | Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut. ( Kankuri, E; Korpela, R; Moilanen, E; Paakkari, I; Vaali, K; Vapaatalo, H, 2001) |
| "Inflammation is a non-specific immune response to infection, irritation or other injury, the key features being redness, warmth, swelling and pain." | 2.49 | Immunoinflammatory responses in gastrointestinal tract injury and recovery. ( Alam, MM; Marella, A; Shaquiquzzaman, M; Verma, G, 2013) |
| " However, long-term use of NSAIDs is associated with substantial gastrointestinal toxicity and may cause an exacerbation in IBD patients." | 2.43 | Chemoprevention for colon cancer: new opportunities, fact or fiction? ( Mulder, CJ; Terhaar Sive Droste, JS; Tuynman, JB; Van Dullemen, HM, 2006) |
| "The role of salicylates in Crohn's disease is limited to the mild activity phase; further data are required to clarify its role in maintenance on remission." | 2.41 | New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. ( Campieri, M, 2002) |
| "Non-aspirin NSAIDs were associated with lower PCCRC risk after a negative baseline colonoscopy." | 1.56 | Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer. ( Chan, EW; Chen, L; Cheung, KS; Leung, WK; Seto, WK; Wong, ICK, 2020) |
| "First, patients with quiescent Crohn's disease and ulcerative colitis received the non-NSAID analgesic acetaminophen (n = 26) and the conventional NSAIDs naproxen (n = 32), diclofenac (n = 29), and indomethacin (n = 22) for 4 weeks." | 1.33 | Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease. ( Bjarnason, I; Bjornsson, E; Maiden, L; Premchand, P; Sherwood, R; Smale, S; Takeuchi, K; Thjodleifsson, B, 2006) |
| "Fifty-eight ulcerative colitis patients were seen with active disease, with eight (13." | 1.31 | Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease. ( Bayona, M; Bonner, GF; Kitchen, L; Walczak, M, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (48.00) | 29.6817 |
| 2010's | 8 (32.00) | 24.3611 |
| 2020's | 5 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leeds, IL | 1 |
| Sklow, B | 1 |
| Gorgun, E | 1 |
| Liska, D | 1 |
| Lightner, AL | 1 |
| Hull, TL | 1 |
| Steele, SR | 1 |
| Holubar, SD | 1 |
| Mak, JWY | 1 |
| So, J | 1 |
| Tang, W | 1 |
| Yip, TCF | 1 |
| Leung, WK | 2 |
| Li, M | 1 |
| Lo, FH | 1 |
| Ng, KM | 1 |
| Sze, SF | 1 |
| Leung, CM | 1 |
| Tsang, SWC | 1 |
| Shan, EHS | 1 |
| Chan, KH | 1 |
| Lam, BCY | 1 |
| Hui, AJ | 1 |
| Chow, WH | 1 |
| Chan, FKL | 1 |
| Ng, SC | 1 |
| Cheung, KS | 1 |
| Chen, L | 1 |
| Chan, EW | 1 |
| Seto, WK | 1 |
| Wong, ICK | 1 |
| Elia, JR | 1 |
| Pekow, J | 1 |
| Patel, P | 1 |
| Imazio, M | 1 |
| Brucato, A | 1 |
| Barbieri, A | 1 |
| Ferroni, F | 1 |
| Maestroni, S | 1 |
| Ligabue, G | 1 |
| Chinaglia, A | 1 |
| Cumetti, D | 1 |
| Della Casa, G | 1 |
| Bonomi, F | 1 |
| Mantovani, F | 1 |
| Di Corato, P | 1 |
| Lugli, R | 1 |
| Faletti, R | 1 |
| Leuzzi, S | 1 |
| Bonamini, R | 1 |
| Modena, MG | 1 |
| Belli, R | 1 |
| Verma, G | 1 |
| Marella, A | 1 |
| Shaquiquzzaman, M | 1 |
| Alam, MM | 1 |
| Singh, S | 1 |
| Kullo, IJ | 1 |
| Pardi, DS | 1 |
| Loftus, EV | 1 |
| Burr, NE | 1 |
| Hull, MA | 1 |
| Subramanian, V | 1 |
| Chan, SS | 1 |
| Hart, AR | 1 |
| Beaugerie, L | 1 |
| Vinod, J | 1 |
| Vadada, D | 1 |
| Korelitz, BI | 1 |
| Sonpal, N | 1 |
| Panagopoulos, G | 1 |
| Baiocco, P | 1 |
| Ananthakrishnan, AN | 1 |
| Vogt, W | 1 |
| García Rodríguez, LA | 1 |
| González-Pérez, A | 1 |
| Johansson, S | 1 |
| Wallander, MA | 1 |
| Takeuchi, K | 1 |
| Smale, S | 1 |
| Premchand, P | 1 |
| Maiden, L | 1 |
| Sherwood, R | 1 |
| Thjodleifsson, B | 1 |
| Bjornsson, E | 1 |
| Bjarnason, I | 1 |
| Terhaar Sive Droste, JS | 1 |
| Tuynman, JB | 1 |
| Van Dullemen, HM | 1 |
| Mulder, CJ | 1 |
| Maillard, MH | 1 |
| Cozzi, F | 1 |
| Podswiadek, M | 1 |
| Cardinale, G | 1 |
| Oliviero, F | 1 |
| Dani, L | 1 |
| Sfriso, P | 1 |
| Punzi, L | 1 |
| Bonner, GF | 1 |
| Walczak, M | 1 |
| Kitchen, L | 1 |
| Bayona, M | 1 |
| Fägerstam, JP | 1 |
| Whiss, PA | 1 |
| Ström, M | 1 |
| Andersson, RG | 1 |
| Kankuri, E | 1 |
| Vaali, K | 1 |
| Korpela, R | 1 |
| Paakkari, I | 1 |
| Vapaatalo, H | 1 |
| Moilanen, E | 1 |
| Marvisi, M | 1 |
| Fornasari, G | 1 |
| Campieri, M | 1 |
| Geboes, K | 1 |
| Dalle, I | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Dexamethasone Versus Methylprednisolone for the Treatment of Active Inflammatory Bowel Disease[NCT00152620] | 40 participants | Interventional | 2004-06-30 | Terminated (stopped due to study completed) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
11 reviews available for aspirin and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Immunoinflammatory responses in gastrointestinal tract injury and recovery.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Aspirin; Biogenic Polyamines; Biomarkers; Cyc | 2013 |
Epidemiology, risk factors and management of cardiovascular diseases in IBD.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cardiovascular Diseases; Clopidogrel; Endothelium, | 2015 |
Does aspirin or non-aspirin non-steroidal anti-inflammatory drug use prevent colorectal cancer in inflammatory bowel disease?
Topics: Anti-Inflammatory Agents, Non-Steroidal; Anticarcinogenic Agents; Aspirin; Colorectal Neoplasms; Evi | 2016 |
Inflammatory bowel disease therapies and cancer risk: where are we and where are we going?
Topics: Aspirin; Colitis; Colorectal Neoplasms; Glucocorticoids; Humans; Immunosuppressive Agents; Inflammat | 2012 |
Environmental triggers for inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Diet; Environment; Humans; Inflammatory Bowel Dise | 2013 |
[Inflammatory bowel disease--diagnosis and therapy].
Topics: Adrenal Cortex Hormones; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Azathioprine; Colitis, Ul | 2005 |
Chemoprevention for colon cancer: new opportunities, fact or fiction?
Topics: Age Factors; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colonic Neoplasms; Colorectal Neoplas | 2006 |
[Resolvins: new derivates of fatty acids, polyunsaturated (omega-3) with therapeutic potential in inflammatory intestinal diseases].
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Aspirin; Docosahexaenoic Acids; | 2006 |
[Is the lung a target organ in inflammatory bowel disease?].
Topics: Adrenal Cortex Hormones; Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Bronchial Diseases | 2001 |
New steroids and new salicylates in inflammatory bowel disease: a critical appraisal.
Topics: Acute Disease; Aspirin; Beclomethasone; Budesonide; Colitis, Ulcerative; Crohn Disease; Drug Therapy | 2002 |
Influence of treatment on morphological features of mucosal inflammation.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Child; Colitis, Ulcerative; Crohn Disease; | 2002 |
1 trial available for aspirin and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Mud-bath treatment in spondylitis associated with inflammatory bowel disease--a pilot randomised clinical trial.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis, Ulcerative; Combined Modality Ther | 2007 |
13 other studies available for aspirin and Bowel Diseases, Inflammatory
| Article | Year |
|---|---|
Cost-Effectiveness of Aspirin for Extended Venous Thromboembolism Prophylaxis After Major Surgery for Inflammatory Bowel Disease.
Topics: Aftercare; Anticoagulants; Aspirin; Cost-Benefit Analysis; Enoxaparin; Humans; Inflammatory Bowel Di | 2022 |
Cancer risk and chemoprevention in Chinese inflammatory bowel disease patients: a population-based cohort study.
Topics: Adult; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; China; Cohort Studies; Colitis, Ulcerative; | 2020 |
Nonsteroidal anti-inflammatory drugs but not aspirin are associated with a lower risk of post-colonoscopy colorectal cancer.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cohort Studies; Co | 2020 |
Aspirin, NSAIDs, and Inflammatory Bowel Disease: An Exercise Physiology Perspective.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis; Humans; Inflammatory Bowel Diseases | 2020 |
Daily Aspirin Use Does Not Impact Clinical Outcomes in Patients With Inflammatory Bowel Disease. Reply Letter to Elia et al.
Topics: Aspirin; Colitis; Humans; Inflammatory Bowel Diseases | 2020 |
Good prognosis for pericarditis with and without myocardial involvement: results from a multicenter, prospective cohort study.
Topics: Acute Disease; Adolescent; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; | 2013 |
Aspirin use and development of inflammatory bowel disease: confounding or causation? authors' reply.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Female; Humans; Inflammatory Bowel Diseases; Male; | 2011 |
The effect of antiplatelet therapy in patients with inflammatory bowel disease.
Topics: Aspirin; Clopidogrel; Disease Progression; Female; Humans; Inflammatory Bowel Diseases; Male; Platel | 2012 |
Risk factors for inflammatory bowel disease in the general population.
Topics: Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents, Non-Steroidal; Appendectomy; Aspirin; Cont | 2005 |
Prevalence and mechanism of nonsteroidal anti-inflammatory drug-induced clinical relapse in patients with inflammatory bowel disease.
Topics: Acetaminophen; Adult; Aged; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Butanones; Colitis, Ul | 2006 |
Tolerance of nonsteroidal antiinflammatory drugs in patients with inflammatory bowel disease.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Colitis, Ulcerative; Crohn Disease; Drug Utilizati | 2000 |
Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease.
Topics: Adult; Aged; Antigens, CD; Aspirin; Blood Platelets; Chemokine CCL5; Female; Humans; Inflammatory Bo | 2000 |
Effects of a COX-2 preferential agent nimesulide on TNBS-induced acute inflammation in the gut.
Topics: Acute Disease; Animals; Aspirin; Colitis; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygen | 2001 |